Inventor · disambiguated record
Daniel Drocourt
Also filed as: DROCOURT DANIEL
11 granted patents·4 pending applications·212 citations·filing 1985–2018
90Inventor score
Files withCAYLA6UNIV TOULOUSE 3 PAUL SABATIER3CENTRE NAT RECH SCIENT2BUSCAIL LOUIS1INST NAT SANTE RECH MED1
Top patents by PatentIndex Score
15 records- 0194US9295732B2Conjugated TLR7 and/or TLR8 and TLR2 polycationic agonistsCAYLA·Filed 2013·Granted Mar 29, 2016·41 cites·4 claims
- 0292US7244609B2Synthetic genes and bacterial plasmids devoid of CpGCAYLA·Filed 2002·Granted Jul 17, 2007·60 cites·12 claims
- 0380US9458184B2Compositions of TLR7 and/or TLR8 agonists conjugated to lipidsCAYLA·Filed 2013·Granted Oct 4, 2016·4 cites·7 claims
- 0480US5021344AApplication of antibiotics of the phleomycin family as selection agent in the field of genetic engineeringCENTRE NAT RECH SCIENT·Filed 1985·Granted Jun 4, 1991·50 cites·1 claims
- 0570US8435777B1CPG-free gene for a new secreted reporter proteinREYNES JEAN PAUL·Filed 2012·Granted May 7, 2013·4 cites·20 claims
- 0670US5856153ASuicide genes and new associations of pyrimidine nucleobase and nucleoside analogs with new suicide genes for gene therapy of acquired diseasesCAYLA·Filed 1994·Granted Jan 5, 1999·24 cites·39 claims
- 0767US5118620AApplication of antibiotics of the phleomycin family as selection agent in the field of genetic engineeringCENTRE NAT RECH SCIENT·Filed 1991·Granted Jun 2, 1992·29 cites·6 claims
- 0859US9364494B2Somatostatin 2 receptor (sst2), deoxycytidine kinase (dck) and uridine monophosphate kinase (umk) pancreatic gene therapyBUSCAIL LOUIS·Filed 2008·Granted Jun 14, 2016·0 cites·13 claims
- 0946US9567336B2Conjugated TLR7 and/or TLR8 and TLR2 agonistsCAYLA·Filed 2013·Granted Feb 14, 2017·0 cites·10 claims
- 1039US2017340658A1Combined use of a chemotherapeutic agent and a cyclic dinucleotide for cancer treatmentINVIVOGEN·Filed 2015·Application pending·0 cites
- 1137US2011008894A1Lyophilized plasmid/dna transfection reagent carrier complexCAYLA·Filed 2010·Application pending·0 cites
- 1234US9637538B2Anti-HLA monoclonal chimeric immunoglobulin, process and kit employing such a monoclonal chimeric immunoglobulinUNIV TOULOUSE 3 PAUL SABATIER·Filed 2013·Granted May 2, 2017·0 cites·5 claims
- 1334US2015190480A1Combination products for treating cancerINST NAT SANTE RECH MED·Filed 2015·Application pending·0 cites
- 1434US2019135924A1Anti-hla monoclonal chimeric immunoglobulin, process and kit employing such a monoclonal chimeric immunoglobulinUNIV TOULOUSE 3 PAUL SABATIER·Filed 2018·Application pending·0 cites
- 1532US10705076B2Anti-HLA monoclonal chimeric immunoglobulin, method and kit implementing such a monoclonal chimeric immunoglobulinUNIV TOULOUSE 3 PAUL SABATIER·Filed 2013·Granted Jul 7, 2020·0 cites·7 claims
Join the waitlist — get patent alerts
Get an alert when Daniel Drocourt files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →